"Hi xxx,

Thank you for your questions. We are very excited to be working with Cencora to help us accelerate the commercialization of ZEN-3694. As was mentioned in the recent press release, the initial focus of Cencora’s work will be in evaluating regulatory and market access to provide insights into potential barriers and opportunities for ZEN-3694's introduction. I understand that you are eager to learn more about this agreement, but I do not have additional details to share with you at this time.

Thank you for your patience and understanding.

Best regards,

Chris"